Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc MMIRF


Primary Symbol: V.MIR

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > Mir
View:
Post by dodyoli on Feb 18, 2021 10:11am

Mir

https://www.nejm.org/doi/full/10.1056/NEJMp2033687?query=featured_secondary

FDA-N
o more sales until approval
You all need to read it, it was issued by the FDA yesterday
Comment by conservative2 on Feb 18, 2021 10:29am
I disagree with your assertion. Initially FDA rushed through the process of granting Emergency Use with poor checks and balances in place, which allowed poor tests to get on the market that did not perform. Their assessment process is now extremely rigorous. Those test that now make it through the accreditation proceess will test for covid with reliability and accuracy. MIRs test will be one of ...more  
Comment by Red~One on Feb 18, 2021 10:46am
Yes and no, what the article say is that the FDA admits it allowed too many serology tests and that users were reading the data wrong an assuming it was testing for Covid infection whereas it was also seeing past infections and giving misleading data. Ergo the FDA are saying between the lines that they want more accurate tests that test for antibodies (and in my thinking it would follow that MIR ...more  
Comment by Red~One on Feb 18, 2021 10:33am
Interesting this bodes well
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse